SLS
SELLAS Life Sciences Group, Inc.
-0.20 (-1.67%)11.47USD2.5M成交股數2.3B市值–本益比(近四季)29307.7股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | 79K | 0 | 0 | 0 |
| 營業成本 | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 毛利 | – | – | – | – | – | – | – | – | – | 0 | 0 | 0 |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 6.3M | 5.1M | 4.7M | 4.2M | 3.9M | 3.2M | 4.4M | 5.2M | 5.1M | 5.1M | 5.8M | 5.9M |
| 銷售管理費用 | 4.4M | 4.1M | 3.5M | 2.9M | 3.0M | 2.9M | 3.0M | 2.4M | 4.5M | 3.1M | 3.5M | 3.1M |
| 營業利益 | −10.6M+55% | −9.3M+53% | −8.3M+13% | −7.1M-7% | −6.9M-29% | −6.1M-26% | −7.3M-22% | −7.6M-16% | −9.6M | −8.2M | −9.4M | −9.1M |
| 營業利益率 | – | – | – | – | – | – | – | – | -12,208.9% | – | – | – |
| 稅後淨利 | −9.6M+46% | −8.4M+45% | −7.7M+8% | −6.8M-9% | −6.6M-31% | −5.8M-29% | −7.1M-23% | −7.5M-15% | −9.6M | −8.1M | −9.3M | −8.8M |
| 淨利率 | – | – | – | – | – | – | – | – | -12,108.9% | – | – | – |
| 稀釋 EPS | -0.05-29% | -0.05-29% | -0.05-50% | -0.06-54% | -0.07-67% | -0.07-70% | -0.10-70% | -0.13-58% | -0.21 | -0.23 | -0.33 | -0.31 |
| 稀釋股數 | 189M | 172M | 109M | 108M | 98.6M | 87.8M | 68.3M | 57.6M | 44.8M | 27.8M | 28.4M | 28.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 138M | 107M | 71.8M | 44.3M | 25.3M | 28.4M | 21.0M | 9.1M | 18.4M | 2.5M | 4.0M | 13.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 145M | 114M | 78.3M | 51.6M | 32.3M | 35.0M | 26.5M | 15.1M | 24.4M | 6.2M | 8.1M | 18.6M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 7.7M | 6.8M | 7.5M | 5.9M | 6.2M | 7.2M | 10.6M | 12.2M | 14.8M | 14.2M | 11.9M | 13.7M |
| 股東權益 | 138M | 107M | 70.9M | 45.6M | 26.1M | 27.8M | 15.9M | 2.9M | 9.7M | −8.0M | −3.8M | 4.8M |
| 負債比 | 5.3% | 5.9% | 9.5% | 11.5% | 19.1% | 20.6% | 40.0% | 80.7% | 60.4% | 228.3% | 147.3% | 73.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −8.8M-2% | – | – | – | −9.1M | – | – | −10.8M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −26.9M | –% | -0.25 | – |
| FY2024 | – | – | −30.9M | –% | -0.50 | – |
| FY2023 | 0 | -100.0% | −37.3M | –% | -1.34 | – |
| FY2022 | 1.0M | -86.8% | −41.3M | -4,130.1% | -2.13 | – |
| FY2021 | 7.6M | +300.0% | −20.7M | -272.4% | -1.34 | – |
| FY2020 | 1.9M | – | −16.8M | -881.9% | -2.11 | – |
| FY2019 | 0 | -100.0% | −19.3M | –% | -10.92 | – |
| FY2018 | −266K | – | −27.7M | 10,402.3% | -157.72 | – |